Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Madrigal Pharmaceuticals Inc (MDGL)

Madrigal Pharmaceuticals Inc (MDGL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 4,892,809
  • Shares Outstanding, K 21,312
  • Annual Sales, $ 0 K
  • Annual Income, $ -373,630 K
  • 60-Month Beta -0.33
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 5.74
Trade MDGL with:

Options Overview Details

View History
  • Implied Volatility 56.83% ( -0.35%)
  • Historical Volatility 54.72%
  • IV Percentile 17%
  • IV Rank 8.37%
  • IV High 156.35% on 02/23/24
  • IV Low 47.74% on 03/28/24
  • Put/Call Vol Ratio 0.08
  • Today's Volume 853
  • Volume Avg (30-Day) 601
  • Put/Call OI Ratio 0.53
  • Today's Open Interest 28,299
  • Open Int (30-Day) 29,932

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 15 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/24
See More
  • Average Estimate -7.55
  • Number of Estimates 9
  • High Estimate -6.52
  • Low Estimate -9.37
  • Prior Year -4.69
  • Growth Rate Est. (year over year) -60.98%

Price Performance

See More
Period Period Low Period High Performance
1-Month
191.18 +16.79%
on 04/29/24
250.34 -10.81%
on 05/22/24
+29.96 (+15.50%)
since 04/26/24
3-Month
189.00 +18.14%
on 04/26/24
299.98 -25.57%
on 03/15/24
-30.94 (-12.17%)
since 02/28/24
52-Week
119.76 +86.45%
on 10/27/23
299.98 -25.57%
on 03/15/24
-61.59 (-21.62%)
since 05/26/23

Most Recent Stories

More News
Is Madrigal Pharmaceuticals Stock a Buy?

It's not the most prominent biotech, but it has an important claim to fame.

MDGL : 223.29 (-2.74%)
Madrigal: Q1 Earnings Snapshot

Madrigal: Q1 Earnings Snapshot

MDGL : 223.29 (-2.74%)
2 Under-the-Radar Growth Stocks to Consider

Don't ignore these innovative companies.

MDGL : 223.29 (-2.74%)
AXSM : 76.76 (+2.09%)
Better Booming Biotech Stock: Madrigal Pharmaceuticals vs. Viking Therapeutics

These businesses should see good times ahead.

MDGL : 223.29 (-2.74%)
VKTX : 65.36 (+4.16%)
1 No-Brainer Growth Stock to Buy Now

This liver-disease specialist might be significantly undervalued.

MDGL : 223.29 (-2.74%)
Better Buy: Viking Therapeutics vs. Madrigal Pharmaceuticals

Both stocks are pretty risky, but one of them more so than the other.

VKTX : 65.36 (+4.16%)
MDGL : 223.29 (-2.74%)
Is This Healthcare Stock a Screaming Buy After Scoring a Huge Drug Approval?

Could it be just a matter of time before Madrigal Pharmaceuticals stock takes off?

MDGL : 223.29 (-2.74%)
Here's 1 Huge New Reason to Buy Madrigal Pharmaceuticals Stock

This biotech just got clearance to dive into a deep ocean of a market.

MDGL : 223.29 (-2.74%)
This Under-the-Radar Stock Just Hit a Major Milestone: Time to Buy?

The mid-cap biotech has succeeded where many others failed.

MDGL : 223.29 (-2.74%)
Is Madrigal Pharmaceuticals Stock a Better Buy Than Eli Lilly and Novo Nordisk After Its Huge FDA Win?

Madrigal has one key advantage over its two huge potential future rivals.

LLY : 807.86 (+0.05%)
NVO : 134.08 (-1.44%)
MDGL : 223.29 (-2.74%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 16% Buy with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Madrigal Pharmaceuticals, Inc. is engaged in developing small-molecule drugs addressing cardiovascular and metabolic diseases. Its products pipeline include MGL-3196, an orally administered liver-directed thyroid hormone receptor-' agonist that is used for the treatment of NASH, dyslipidemia/hypercholesterolemia...

See More

Key Turning Points

3rd Resistance Point 241.15
2nd Resistance Point 237.35
1st Resistance Point 230.32
Last Price 223.29
1st Support Level 219.49
2nd Support Level 215.69
3rd Support Level 208.66

See More

52-Week High 299.98
Fibonacci 61.8% 231.14
Last Price 223.29
Fibonacci 50% 209.87
Fibonacci 38.2% 188.60
52-Week Low 119.76

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar